TEVA PHARMS USA INC FDA Approval ANDA 206854

ANDA 206854

TEVA PHARMS USA INC

FDA Drug Application

Application #206854

Application Sponsors

ANDA 206854TEVA PHARMS USA INC

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MG0DALFAMPRIDINEDALFAMPRIDINE

FDA Submissions

UNKNOWN; ORIG1TA2016-07-19STANDARD

Submissions Property Types

ORIG1Null1

CDER Filings

TEVA PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206854
            [companyName] => TEVA PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DALFAMPRIDINE","activeIngredients":"DALFAMPRIDINE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/19\/2016","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-07-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.